View in EDS

Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin.

Saved in:
Bibliographic Details
Title: Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin.
Authors: Gu YH; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China., Shen YC; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China., Ou-Yang Y; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China., Rao XM; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China., Fu DD; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China., Wen FQ; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Source: Molecular therapy oncolytics [Mol Ther Oncolytics] 2021 Jun 01; Vol. 22, pp. 565-573. Date of Electronic Publication: 2021 Jun 01 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34553041
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gu+YH%22">Gu YH</searchLink>; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.<br /><searchLink fieldCode="AU" term="%22Shen+YC%22">Shen YC</searchLink>; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.<br /><searchLink fieldCode="AU" term="%22Ou-Yang+Y%22">Ou-Yang Y</searchLink>; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.<br /><searchLink fieldCode="AU" term="%22Rao+XM%22">Rao XM</searchLink>; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.<br /><searchLink fieldCode="AU" term="%22Fu+DD%22">Fu DD</searchLink>; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.<br /><searchLink fieldCode="AU" term="%22Wen+FQ%22">Wen FQ</searchLink>; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101666776%22">Molecular therapy oncolytics</searchLink> [Mol Ther Oncolytics] 2021 Jun 01; Vol. 22, pp. 565-573. <i>Date of Electronic Publication: </i>2021 Jun 01 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101666776 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2372-7705 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223727705%22">23727705 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncolytics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34553041
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omto.2021.05.011
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 565
    Titles:
      – TitleFull: Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gu YH
      – PersonEntity:
          Name:
            NameFull: Shen YC
      – PersonEntity:
          Name:
            NameFull: Ou-Yang Y
      – PersonEntity:
          Name:
            NameFull: Rao XM
      – PersonEntity:
          Name:
            NameFull: Fu DD
      – PersonEntity:
          Name:
            NameFull: Wen FQ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2021 Jun 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2372-7705
          Numbering:
            – Type: volume
              Value: 22
          Titles:
            – TitleFull: Molecular therapy oncolytics
              Type: main
ResultId 1